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Abstract 
Somatic hypermutation of immunoglobulin variable region (IgV) genes and affinity maturation 
of the antibody response are the hallmarks of the germinal center (GC) reaction in T cell-
dependent immune responses. Determining the consequences of the experimental manipulation 
of the GC response on somatic hypermutation and affinity maturation requires the availability of 
a system that allows measuring these parameters. Immunization of mice of the C57/Bl6 genetic 
background with the hapten 4-hydroxy-3-nitrophenyl-acetyl (NP) coupled to a carrier protein 
leads to the predominant usage of one particular IgV heavy chain gene segment, V186.2, among 
the responding B cells. Moreover, a specific somatic mutation in codon 33 of V186.2 that leads 
to a tryptophan to leucine amino-acid exchange increases the affinity of the corresponding 
antibody by ~10-fold, thus representing a molecular marker for affinity maturation. In addition, 
due to the simplicity of the antigen and the virtual absence of NP-specific plasma cells prior to 
immunization, NP-based immunizations represent ideal tools to quantify the plasma cell 
response by measuring NP-specific antisera by ELISA and the generation of NP-specific plasma 
cells by ELISPOT analysis. We here describe approaches to i) measure the anti-NP plasma cell 
response by ELISA and ELISPOT analysis, and to ii) amplify and sequence V186.2 
rearrangements from GC B cells and plasma cells to determine the level of somatic 
hypermutation and the extent of affinity maturation in the anti-NP response.     
 
Key Words 
B cell; plasma cell; Ig variable region gene; germinal center; somatic hypermutation; affinity 
maturation; T cell-dependent; T cell-independent   
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1. Introduction 
Antigen-specific memory B cells and plasma cells are generated during the germinal center (GC) 
reaction of T cell-dependent immune responses in secondary lymphoid tissues (1, 2). Within the 
GC microenvironment, antigen-activated B cells undergo somatic hypermutation of the 
rearranged IgV genes with the aim to generate high-affinity antibodies that effectively bind to the 
invading pathogen, resulting in its elimination. In a defined area within the GC called dark zone, 
the rapidly proliferating µdark zone¶ cells hypermutate their IgV genes and then differentiate into 
µlight zone¶ cells that are positively selected for improved antigen-binding in the GC light zone 
(2-5). Selected light zone B cells recirculate to the dark zone to undergo additional rounds of 
mutation and selection to further improve antigen-affinity before they eventually differentiate 
into memory B cells or plasma cells that exit the GC. The descendants of the GC reaction thus 
carry somatically mutated IgV genes and have often switched from IgM to other Ig classes which 
have different effector functions. 
Understanding the molecular mechanism of the GC response is critical for the 
development of improved vaccines against microorganisms. Thus, for studies aimed at 
manipulating the GC response, which e.g. may include the deletion or overexpression of GC-
associated genes or the use of particular adjuvants, it is imperative to have tools that allow the 
investigation of the processes that underlie the generation of antigen-specific memory B cells 
and plasma cells, i.e. somatic hypermutation and antibody affinity maturation. In C57/Bl6 mice, 
the immune response against the hapten 4-hydroxy-3-nitrophenyl-acetyl (NP) coupled to a 
carrier protein frequently results in a specific, affinity-enhancing hypermutation in codon 33 of 
the V186.2 gene segment that leads to an amino acid exchange resulting in a ~10-fold increase in 
affinity against NP (6-8), allowing for the generation of NP-specific GC B cells, memory B cells 
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and plasma cells to be tracked at the molecular level. The resulting antibodies are mostly of the 
IgG1 class (6-8). The characterization of the B-cell response against NP at the molecular level by 
several groups (9-11) provided the baseline for numerous studies on the extent of affinity 
maturation in situations where certain genes were either knocked out in the mouse germ-line or 
conditionally deleted in GC B cells (12-16). 
 By immunizing mice with NP coupled to a carrier protein such as chicken 
gammaglobulin (CGG) or keyhole limpet hemocyanin (KLH), the characteristics and dynamics 
of the immune response against the hapten in the presence or absence of a certain signaling 
pathway or transcription factor, or a specific treatment, can be investigated by i) determining the 
somatic hypermutation frequency in V186.2 gene rearrangements, ii) the fraction of B cells with 
the affinity-enhancing tryptophan to leucine amino-acid exchange, iii) the quantity of NP-
specific serum IgG1 secreted by GC-derived plasma cells by ELISA, and iv) the frequency of 
plasma cells in lymphoid tissues by ELISPOT analysis. The use of the NP system is not confined 
to T cell-dependent antibody responses, as the coupling of NP to lipopolysaccharide (LPS) or the 
polysaccharide Ficoll allows the study of the plasma cell response in T cell-independent 
responses type I and II, respectively, by ELISA. 
 
2. Materials  
2.1 Immunization 
x Sterile phosphate-buffered saline (PBS). 
x NP-KLH (e.g. NP28-KLH, Biosearch Technologies; of note, the number of NP molecules 
conjugated to KLH varies among batches). 
5 
 
x For T-independent immunizations (Notes 1), NP-LPS and NP-AECM-FICOLL 
(Biosearch Technologies).  
x Freud's adjuvant complete.  
x Freud's adjuvant incomplete. 
x 1 ml syringes. 
x Needles (18G1½ and 25G5/8). 
x Vortex. 
x Sonicator. 
2.2 Acquisition of blood samples and serum preparation 
x Razor blade or scalpel. 
x 1 ml or 2 ml syringes. 
x 21G1 needles. 
x 1.5 ml collection tubes. 
x Centrifuge. 
 
2.3 ELISA 
x 96-well immune plates (Thermo Fisher Scientific).  
x 96-well culture plates. 
x Parafilm. 
x PBS. 
x 2% fetal bovine serum (FBS) in PBS. 
x Wash buffer: PBS containing 0.05% Tween-20. 
x Capture antibody: anti-mouse Ig(H+L) (Southern Biotec). 
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x NP-bovine serum albumin (BSA) with low and high hapten coating (e.g. NP9-BSA and 
NP25-BSA). 
x Mouse Ig (e.g. IgM, IgG1). 
x Detection antibody: alkaline phosphatase (AP)-conjugated anti-mouse Ig (e.g. IgM, 
IgG1). 
x PNPP (p-nitrophenylphosphate; Southern Biotec).  
x Substrate buffer (500 ml): ddH2O + 24.5 mg MgCl2x6H2O + 48 ml diethanolamine; 
adjust pH to 9.8 with 5N HCl. 
x Microplate reader. 
 
2.4 Sample generation from mouse tissues following NP immunization 
x PBS/0.5% BSA 
x Glass slides; alternatively 40 µm cell strainer, 50 ml falcon tube and plunger of a 5 ml 
syringe. 
x 10 ml syringes. 
x 22G1 needles. 
x RBC lysis buffer (e.g. Red Blood Cell Lysis HybriMax; Sigma Aldrich); alternatively, 
prepare lysis buffer: ammonium chloride (NH4Cl) 0.15 M, 8.29 g per l; potassium 
bicarbonate (KHCO3) 10 mM, 1 g per l; EDTA  0.1 mM, 0.037 g per l; H2O, 1 l; filter 
VROXWLRQZLWKȝPILOWHUVWRUHDWºC. 
x 15 ml Falcon tubes. 
x Refrigerated centrifuge. 
x Optional: cell counter (e.g. Countess, Invitrogen). 
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2.5 ELISPOT 
x 96-well filtration plates (Millipore, Cat# MSIPS4510). 
x 96-well culture plates. 
x Plastic wrap. 
x 0.2 µm filter.  
x 35% ethanol (diluted in molecular grade H2O). 
x Sterile PBS. 
x RPMI culture medium supplemented with 10% fetal bovine serum (FBS), 1% 
Penicillin/Streptomycin and 0.1% E-mercaptoethanol.  
x Wash buffer: PBS containing 0.05% Tween-20. 
x PBS/2% BSA. 
x NP-BSA with high hapten coating (e.g. NP25-BSA). 
x Detection antibody: AP-conjugated anti-mouse IgG1.  
x Nitro blue tetrazolium chloride-5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP; 
Roche). 
x NBT/BCIP substrate buffer: 0.1 M Tris + 0.1 M NaCl + 0.05 M MgCl2; pH 9.5. 
x Optional: cell counter. 
x Microplate reader (alternatively, colonies can be counted using a magnifying glass and 
pictures of wells can be taken with a camera that has a macro function). 
2.6 Isolation of B-cell subsets from immunized mice by FACS  
x RBC lysis buffer (see above). 
x PBS/0.5% BSA. 
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x Glass slides; alternatively 40 µm cell strainer, 50 ml falcon tube and plunger of a 5 ml 
syringe. 
x 15 ml Falcon tubes. 
x MidiMACS Separator (Miltenyi Biotech). 
x MidiMACS Separation Units (columns) (Miltenyi Biotech). 
x µ8QWRXFKHG¶%-cell isolation kit (Miltenyi Biotech). 
x Antibodies: B220-PercP, CD95-PE, CD138-PE (conjugates available from various 
companies), PNA-biotin (Vector Laboratories), streptavidin-FITC (or streptavidin-APC if 
mouse cells are GFP+ or YFP+). 
x Fluorescent-activated cell sorter (FACS; e.g. provided by the LQVWLWXWLRQµVVWDII-operated 
Flow Cytometry Core Facility). 
x 15 ml, 5 ml or 1.5 ml collection tubes. 
x Collection buffer: PBS/BSA with 20% fetal bovine serum (FBS). 
x Refrigerated centrifuge.  
2.7 Sequencing of V186.2 gene rearrangements amplified from RNA 
x TRIzol Reagent (Invitrogen). 
x 26G½ needles and 1 ml syringes. 
x Chloroform. 
x Isopropanol. 
x Glycogen. 
x DEPC-treated water. 
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x UV spectrometer (e.g., NanoDrop ND-8000 Spectrophotometer; NanoDrop 
Technologies). 
x cDNA synthesis kit (e.g. from Invitrogen or an equivalent kit). 
x PCR thermocycler. 
x PCR tubes. 
x dNTPs. 
x Gene-specific primers (Table 1). 
x Taq polymerase and reagents for PCR amplification. 
x Gel electrophoresis unit with appropriate buffer. 
x Agarose and agarose plates. 
x Ethidium bromide. 
x Gel imaging system. 
x TA-cloning vector; pGEM-TEasy (Promega). 
x Competent bacteria (DH5D). 
x SOC medium. 
x Ampicillin.  
 
3. Methods 
3.1 Primary and secondary immunization with NP 
The general approach is summarized in Fig. 1.   
 3.1.1 Preparation of a NP-KLH emulsion 
1. Dissolve NP-KLH in sterile PBS at a concentration of 1 mg/ml.  
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2. For primary immunizations, NP-KLH is mixed with complete Freud's adjuvant at 
a 1:1 ratio (for the use of an alternative adjuvant, alum, see Notes 2). Prepare 2.5±
3x of the volume needed to ensure sufficient immunization emulsion for all 
experimental mice.  
3. Vortex the mixture for 10 min and subsequently sonicate 3x for 5 min at 30 sec 
intervals.  
4. For secondary challenges, mix NP-KLH at a 1:5 ratio with sterile PBS. The 
diluted NP-KLH solution is then mixed with incomplete Freud's adjuvant at a 1:1 
ratio and processed as described.  
5. For T-independent immunizations, see Notes 1. 
3.1.2 Immunization 
1. Fill a 1 ml syringe with the NP-KLH emulsion by using a 18G1½ needle. Use the 
same syringe for all mice. If immunizing many mice, fill as few syringes as 
possible.  
2. Remove the needle and compress the mixture by drawing the punch up and down 
several times to remove the air.  
3. For injection, attach a 25G5/8 needle and intraperitoneally inject 200 Pl per 
mouse.  
3.2 Detection of NP-specific Ig by ELISA 
3.2.1 Collection and preparation of serum from immunized mice 
1. Prior to and at different time-points following NP immunization (7 days before 
immunization, day 14 and day 28 after immunization), take a few drops of blood 
from the tail vein of the mice using a razor blade or scalpel or by an alternative 
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IACUC-approved method from live mice and collect into 1.5 ml collection tubes 
(important: no addition of heparin). At the final time point, withdraw peripheral 
blood (any volume from a drop to several hundred Pl is fine) with a 21G1½ 
needle and a 1 or 2 ml syringe from the heart of sacrificed mice and transfer to a 
1.5 ml reaction tube. 
2. Keep reaction tube at RT for the remainder of the day and at 4ºC o/n to allow 
clotting. 
3. Centrifuge at 12,000xg for 5 min and carefully transfer the clear supernatant 
(serum) to a new 1.5 ml reaction tube. 
4. Repeat the process to remove any clotted material and store serum at ±20 ºC until 
use.    
3.2.2 Detection of NP-specific Ig 
1. Coat one or more 96-well immune plates with 50 Pl per well of 2.5 Pl/ml NP9-
BSA, and the same amount of plates with NP25-BSA diluted in PBS (the latter is 
necessary only if one plans to determine also the specificity of the secreted 
antibodies for an affinity maturation analysis; see 3.2.2.12 below). In doing so, 
skip the first row of each plate and coat instead with 2.5 Pl/ml capture antibody 
diluted in PBS to later generate a standard curve. Seal the plates with parafilm and 
incubate over night at 4°C. Discard the solution and wash the wells 3x with 200Pl 
wash buffer. 
2. Apply 200Pl of PBS/2% FBS per well, seal the plates with parafilm and incubate 
at room temperature for at least 1 hour. 
3. Discard the solution and wash the wells 3x with 200 Pl wash buffer. 
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4. In the first row of each plate, generate a standard curve (of e.g. IgM, IgG1) with 
each 50 Pl of 400 - 200 - 100 - 50 - 25 - 12.5 - 6.25 - 0 ng/ml. 
5. In a separate 96-well plate, generate 1:2 serial dilutions in PBS/2% FBS of each 
serum sample, starting with a 1:8,000 dilution and ending with a 1:64,000 
dilution. Do every condition in duplicate. Add 50 Pl of each sample dilution to 
one test plate coated with NP9-BSA, and one test plate coated with NP25-BSA 
(use the same order of samples and dilutions on both plates!). Seal the plates with 
parafilm and incubate for 2 hours at room temperature.  
6. Discard the samples and wash the wells 3x with 200 Pl wash buffer. 
7. Add 50 Pl of detection antibody diluted 1:2,000 in PBS/2% FBS to each well. 
Seal the plates and incubate at room temperature for 1 hour. 
8. Discard the solution and wash the wells 5x with 200 Pl wash buffer. 
9. Dissolve one PNPP 5 mg tablet in 5 ml substrate buffer and apply 50 Pl to each 
well. Incubate at RT for 10-30 min, depending on the intensity of color 
development.   
10. Read the plates at 405 nm OD.  Save the 'raw data' as well as the 'blanked data' 
and 'calculated concentrations' in an Excel data sheet. 
11. For analysis of the amount of secreted NP-specific antibodies, plot the standard 
curve and include all sample values of the NP9-BSA-coated plate that lie within 
the linear range of the standard curve, indicated by similar Ig concentrations at 
different sample dilutions. An average of at least two different dilutions in 
duplicate is recommended for analysis.  
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12. To estimate the specificity of the secreted antibodies, analyze the NP25-BSA-
coated plate in the same way as described above, and calculate the ratio of high-
affinity (NP9-BSA):total NP-specific antibodies (NP25-BSA) for each sample and 
dilution in the linear range of the standard curve. If for example in a hypothetical 
knockout genotype the NP9/NP25 ratio was lower compared to the proficient 
controls, this would indicate that affinity maturation in this genotype is impaired.   
13. For T-independent immunization, see Notes 1. 
3.3 Detection of antibody secretion by ELISPOT 
All steps on day 1 and day 2 have to be performed under the hood to keep the plates sterile. Do 
every condition in duplicate. The general approach is summarized in Fig. 1.  
 3.3.1 Preparation of the plates (day 1) 
1. Pre-wet each well of a filtration plate with 15 Pl of 35% ethanol for a maximum 
of 1 min. 
2. Wash each well of the plate 3x with 200 Pl sterile PBS. 
3. Coat each well with 100 Pl of 5 mg/ml NP-BSA (e.g. NP25-BSA) diluted in PBS. 
Wrap the plate tightly in plastic wrap and incubate at 4°C o/n. 
 3.3.2 Sample preparation (day 2) 
4. At least 2 hours before addition of the samples, discard the coating solution and 
wash the plate 3x with sterile PBS.  
5. Block the plate with 100 Pl per well with culture medium (RPMI) for at least 2 
hours at 37°C. 
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6. In the meantime, collect the spleen and/or bone marrow samples from NP-
immunized mice at day 14 or day 28, respectively. Isolate splenic mononuclear 
cells (SMC) in PBS/0.5% BSA by mincing the spleen between glass slides (rough 
surfaces) or using a 40 Pm Falcon cell strainer placed on top of a 50 ml Falcon 
tube and a plunger from a 5 ml syringe to mince the spleen with occasionally 
flushing with ice-cold PBS/0.5% BSA. Bone marrow cells are isolated by 
flushing the femurs with PBS/0.5% BSA. Spin down at 4°C in a 15 ml Falcon and 
resuspend in RBC lysis buffer for 5 min, then add 10 ml PBS/BSA and spin; after 
UHVXVSHQGLQJLQPOOHWWKH³JKRVWV´VHWWOHDQGWUDQVIHUVXSHUQDWDQWLQWR a new 
15 ml tube.  
7. Count the cells (e.g. using a cell counter) and resuspend at the desired cell density 
(e.g. 1x106 cells/ml for SMCs, 8x106 cells/ml for bone marrow) in pre-warmed 
culture medium (RPMI). 
8. Generate 1:2 dilution series for each sample in a separate 96-well culture plate, 
starting with 250,000 cells for SMCs, and 2x106 cells for bone marrow cells.  
9. Decant the blocking medium of the filtration plate and add 100 Pl of each sample 
dilution, resulting in a starting cell number of 100,000 for SMCs and 800,000 
cells for bone marrow samples. 
10. Incubate the samples over night at 37°C and 5% CO2. During this time, do not 
open the incubator door, as it may result in smeared spots difficult to read.  
3.3.3 Spot development (Day 3) 
The following steps can now be performed on the benchtop. 
11. Discard the cell solution and wash the plate 6x with wash buffer.  
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12. To each well, add 100 Pl of AP-conjugated anti-mouse IgG1 diluted 1:2000 in 
PBS/2% BSA. Filter the detection antibody solution prior to use (0.2 µm filter). 
Incubate for 1 hour at RT. 
13. Discard the detection antibody and wash the plate 3x with wash buffer, followed 
by 3 washes with PBS-only to avoid interference of Tween with spot 
development.  
14. Take 200 Pl NBT/BCIP stock solution per 10 ml NBT/BCIP substrate buffer, pass 
the solution through a 0.2 µm filter and apply 100 Pl per well. Incubate for 5-10 
min. 
15. Stop spot development under running water and wash the plate extensively. While 
washing, remove the underdrain and continue rinsing.  
16. Blot the plate on paper towels and leave it to dry under the hood in the dark. 
17. Read the plate in a microplate reader or determine number of spots by alternative 
methods.  
3.4 Isolation of B-cell subsets from immunized mice by FACS 
3.4.1 Isolation of mononuclear cells and B cells 
1. Isolate splenic mononuclear cells in PBS/0.5% BSA at day 14 after immunization 
(Notes 3) by mincing the spleen between glass slides (rough surfaces) or using a 40 
Pm Falcon cell strainer placed on top of a 50 ml Falcon tube and a plunger from a 5 
ml syringe to mince the spleen with occasional flushing with PBS/0.5% BSA. 
2. Spin down in a 15 ml Falcon and resuspend in RBC lysis buffer for 5 min, then add 
10 ml PBS/0.5% BSA DQGVSLQDIWHUUHVXVSHQGLQJLQPOOHWWKH³JKRVWV´VHWWOH
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and transfer supernatant into a new 15 ml tube, count cells. This fraction should be 
used when flow-cytometrically isolating plasma cells (CD138hiB220low). 
3. Isolate mouse B-cells by magnetic cell separation using the MidiMACS system 
ZLWK WKH ³XQWRXFKHG %-FHOO LVRODWLRQ NLW´ (Miltenyi Biotech) according to the 
manufacturer¶s instructions or an equivalent system from another manufacturer; 
count cells. 
3.4.2 Isolation of B-cell subsets by FACS 
4. The cell count of B cells after magnetic cell separation is appr. 107 cells, although it 
can be highly variable. Staining for flow cytometric isolation should be performed 
in a 15 ml Falcon tube. Antibody concentrations need to be titrated which can be 
done on an analyzer (e.g. FACSCalibur or equivalent instrument) using less cells 
and antibody, which is then scaled up for sorting. As a rule of thumb, staining of 
107 B cells can be performed in 100 Pl total staining volume with each 5 Pl of 
antibodies purchased from Pharmingen; antibodies from other companies including 
Biolegend or Bioscience usually require titration. For the isolation of splenic GC B 
cells, stain B cells isolated by magnetic cell separation with antibodies recognizing 
B220 and CD95 and PNA (Fig. 2; for alternative strategies, see Notes 4&5). For 
the isolation of splenic plasma cells, stain mononuclear cells with antibodies 
recognizing B220 and CD138 (Fig. 2). Staining is for 10 min on ice, followed by 
washing with PBS/0.5% BSA and resuspending the cells in appr. 2 ml PBS/0.5% 
BSA (inquire the appropriate cell density of the fraction to be sorted from the cell 
sorter operator). 
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5. Prepare collection tubes according to the following criteria: Depending on the 
number of cells that are expected to be recovered, either 15 ml Falcon tubes, 5 ml 
tubes or 1.5 ml reaction tubes should be used (inquire with the cell sorter operator 
about the best strategy). As a rule of thumb, for the isolation of GC B cells from 
immunized normal mice, 15 ml Falcon tubes are recommended; if the genotype of 
the mice is associated with the occurrence of reduced numbers of GC B cells, or if 
a subset of GC B cells (e.g. eGFP+ GC B cells) are sorted, 5 ml or 1.5 ml tubes 
represent the best choices. Generally, plasma cells represent a minute population 
and should be sorted into 1.5 ml tubes. Regardless of the size of the tubes, fill the 
tubes completely with PBS/0.5% BSA and incubate for 10 minutes to coat the 
surface; this ensures that the sorted cells slide to the bottom early into the sort. 
After discarding the PBS/0.5% BSA, add 20% FBS in PBS/0.5% BSA (and up to 
50% FBS if the expected cell number is very low) at appr. 1/5th of FROOHFWLRQWXEH¶V 
volume (e.g. 3 ml for a 15 ml tube). 
6. For the isolation of GC B cells, set a lymphocyte scatter gate to exclude dead cells 
and small debris, a second gate to identify B220+ cells, and a third gate to identify 
CD95hiPNAhi GC B cells (Fig. 2). For the isolation of plasma cells, set a 
lymphocyte scatter gate (make certain to include large cells, as plasma cells are 
larger than B cells), and a second gate to identify CD138hiB220low cells (Fig. 2). 
Sort cells into collection tubes. Optional: As control for unmutated V186.2 
rearrangements, CD95±PNAlo B cells can be isolated in parallel, although for this 
purpose we suggest the use of an alternative cell population as control (see Notes 
6).  
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7. Spin down sorted cells, carefully remove the supernatant and lyse the cell pellet in 
800 Pl TRIzol, incubate for 10 min at RT and continue with step 3.5.1, or freeze at 
±20ºC if not continuing with the RNA isolation. 
8. For an alternative approach that does not involve the isolation of B-cell subsets by 
FACS, see Notes 7. For studies where the specific analysis of peripheral blood 
memory B cells is of interest, please refer to ref. (12).             
3.5 Sequencing of V186.2 gene rearrangements amplified from RNA 
3.5.1 RNA isolation and cDNA synthesis 
1. Following incubation for 10 min at RT in 800 Pl Trizol, pass 2x through a G26½ 
needle using a 1 ml syringe to shear the DNA. 
2. Add 160 Pl chloroform and shake vigorously with hand for 15 sec. Incubate for 3 
min at RT. Centrifuge at 4ºC for 15 min at 12,000xg. 
3. Carefully remove the upper layer of the interface and transfer to a new tube 
without touching the interphase. Add 2 Pl glycogen to supernatant. Add 400 Pl 
isopropanol, mix and incubate for 10 min at RT. Centrifuge at 4ºC for 15 min at 
12,000xg. 
4. Remove the isopropanol (leave ~100 Pl); centrifuge again briefly and carefully 
remove remaining supernatant (the RNA pellet is transparent and thus difficult to 
see in isopropanol). Wash pellet with 1 ml 75% ethanol in DEPC-treated water 
(now pellet becomes visible). 
5. Remove ethanol (the remaining drop can be removed using a G26½ needle placed 
on a pipette) and dry the pellet on the bench for 15 min, until ethanol has 
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evaporated. Dissolve RNA in 7 Pl DEPC-treated water. RNA can be stored at ±
80ºC if not continuing with the cDNA synthesis. 
6. Make 2 P0GLOXWLRQVRIWKH&Ȗ-F'1$DQGLIDSSOLFDEOHWKH&ȝ-cDNA) primers 
(Table 1) using DEPC-treated water. 
7. Follow the F'1$V\QWKHVLVSURWRFRODFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV
using 7 Pl RNA (in the case that the total reaction volume is 20 Pl) or less 
depending on the number of sorted cells, and 1 Pl of the &Ȗ-cDNA primer and, if 
amplifying P-transcripts in parallel (see Notes 8), 1 Pl of the CP-cDNA primer. 
Perform the cDNA reaction as instructed up to the incubation with RNase H. 
cDNA can be stored at -20ºC if not continuing with the PCR reaction.  
3.5.2 Semi-nested PCR amplification 
1. For the first round of PCR, prepare a master mix consisting of 8 Pl dNTP solution 
(1.25 mM), 5 Pl 10x PCR reaction buffer, 5 Pl MgCl2 (25 mM), 1 Pl V186.2-
leader primer, 1 Pl CJ1-PCR primer (for PCR primers, see Table 1), and 27.5 Pl 
H2O. Add 2 Pl of cDNA reaction mixture to master mix and then 0.5 Pl of a mix 
of Taq polymerase with 1/60 Pfx polymerase (alternatively, a high fidelity 
polymerase that allows the amplification of low amounts of DNA can be used). 
The PCR program consists of 95ºC 2 min, 20x (95ºC 30 s, 70ºC 30 s, 72ºC 90 s), 
72ºC 5 min, and 10ºC pause. There is no agarose gel analysis at this step. 
2. For the second round of PCR, prepare a master mix consisting of 8 Pl dNTP 
solution (1.25 mM), 5 Pl 10x PCR reaction buffer, 3 Pl MgCl2 (25 mM), 1 Pl 
V186.2-nested primer, 1 Pl CJ1-PCR primer (for PCR primers, see Table 1), and 
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28.5 Pl H2O. Add 3 Pl of 1st round PCR product of each of the experimental 
samples and the water control (!) to master mix and then 0.5 Pl of a mix of Taq 
polymerase with 1/60 Pfx polymerase (alternatively, a high fidelity polymerase 
that allows the amplification of low amounts of DNA can be used). The PCR 
program consists of 95ºC 2 min, 30x (95ºC 30 s, 70ºC 30 s, 72ºC 90 s), 72ºC 5 
min, and 10ºC pause. 
3. Run 5 Pl of the PCR product on an agarose gel. Of note: there should be two 
water controls run along with the experimental samples, one which went through 
the nested PCR to control for potential contamination in the 1st round of 
amplification, and one that controls the 2nd round of amplification. 
4. For a genomic DNA-based strategy to amplify V186.2 rearrangements, see Notes 
9.   
3.5.3 Cloning of V186.2 segments 
1. Gel isolation: Prepare a 1.5% agarose gel with wells large enough for loading of 
50 Pl per well. Add 5 Pl loading buffer to the remaining 45 Pl PCR reaction and 
run on the agarose gel; load marker to identify correct length of PCR product. Cut 
out band with a scalpel using a UV lamp to visualize band and transfer into a 1.5 
ml reaction tube. Isolated band can be stored at 4ºC if not continuing with the gel 
purification. 
2. Isolate PCR product using a suitable gel extraction method such as the QIAquick 
*HO ([WUDFWLRQ NLW 4XLDJHQ RU DQ HTXLYDOHQW NLW XVLQJ WKH PDQXIDFWXUHU¶V
instructions. Elute PCR product with 30 Pl H2O. Measure the DNA concentration 
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e.g. using Nanodrop methodology or agarose gel-based quantification methods. 
Optional: 20 ng of DNA can be loaded onto an agarose gel to verify that all bands 
appear at the same intensity. 
3. A-tailing to allow ligation of PCR product into pGEM-TEasy vector: Dilute 
sample to a concentration of 62.5 ng DNA in 6.4 Pl. If the DNA concentration is 
too low, the volume can be reduced using a SpeedVac centrifuge. Add 1 Pl 10x 
PCR reaction buffer, 0.8 Pl MgCl2 (25 mM), 1.6 Pl dNTPs (1.25 mM), and 0.2 Pl 
Taq polymerase. Mix and incubate for 20 min at 70ºC; place on ice. 
4. Set up a ligation reaction using the pGEM-TEasy vector kit with 5 Pl ligation 
buffer, 0.5 Pl cloning vector, 2 Pl PCR product, 1.5 Pl H2O and 1 Pl T4 ligase, 
which should be added last. Mix and incubate for 1 hour at RT. 
5. Using a standard transformation protocol with DH5D competent bacteria, add 2 Pl 
of the ligation reaction to 50 Pl DH5D. Following heat shock, add 500 Pl SOC 
medium, of which after incubation for 1 hour at 37ºC, 100 Pl are spread onto an 
agar plate that contains ampicillin. The remaining bacteria in SOC medium should 
be kept at 4ºC and can be spread onto agarose plates to obtain additional V186.2-
containing clones. 
6. Colony PCR: Carefully lift colony from plate and transfer into a 0.5 ml reaction 
tube containing 40 Pl H2O, vortex vigorously. Prepare a master mix consisting of 
28.5 Pl H2O, 8 Pl dNTP solution (1.25 mM), 5 Pl 10x PCR reaction buffer, 3 Pl 
MgCl2 (25 mM), 1 Pl V186.2-nested primer, 1 Pl CJ1-PCR primer (for PCR 
primers, see Table 1), and 0.4 Pl Taq polymerase. Add 3 Pl of the sample to the 
master mix. The PCR program consists of 95ºC 2 min, 32x (95ºC 30 s, 70ºC 30 s, 
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72ºC 90 s), 72ºC 5 min, and 10ºC pause. Determine DNA concentration in PCR 
product on agarose gel with suitable quantification marker. Send samples for 
sequencing together with an appropriate primer (e.g. T7 primer) using the 
VHTXHQFLQJFRPSDQ\¶VJXLdelines; e.g. some companies require 4 ng/Pl for direct 
sequencing of PCR products; usually, the company will purify the PCR product in 
house before sequencing, so that removal of excess PCR primers is not required.  
3.5.4. Sequence analysis  
1. The VBASE2 database (http://www.vbase2.org/) (17) is a convenient tool for the 
sequence analysis of V168.2 sequences. Following editing the sequence in the 
spherogram, ZKLFK LQFOXGHV UHPRYLQJDQ\SULPHUVHTXHQFHV IURP WKH¶ DQG¶
ends and verifying the nucleotide sequence versus the A, G, T and C peaks, save 
the sequence in FASTA format and run it against the VBASE2 database. V186.2 
corresponds to musIGHV057. If the sequence is more homologous to other V 
genes, it should be excluded from further analysis. The codon encoding the 
affinity enhancing tryptophan to leucine amino-acid exchange is at position 34 in 
the VBASE2 representation. Most somatic mutations lead to a G to T nucleotide 
exchange (TGG to TTG), but are not restricted to this particular exchange. To 
determine the number of somatic mutations in the V186.2 gene segment, all 
nucleotide exchanges relative to musIGHV057 should be counted with the 
exception to those that are directly at the junction to the diversity (D) gene 
segment, as those nucleotide differences could represent non-germline encoded 
(N) nucleotides added by terminal deoxynucleotidyl transferase (TdT). The 
V186.2 mutation frequency is determined by dividing the number of somatic 
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mutations through the number of V186.2 nucleotides sequenced, excluding N, D, 
and joining (J) sequences.     
4. Notes 
(1)  For the study of T-independent type-I and type-II responses, mice are immunized i.p. with 
20 µg NP-LPS or 30 µg of NP-AECM-FICOLL, respectively, dissolved in sterile PBS 
respectively. Serum is isolated from blood as described in section 3.2.1 7 days following 
immunization. ELISA is performed as described in section 3.2.2, except that the anti-NP serum 
response of IgM and IgG3 antibodies is measured. 
(27KHDGMXYDQWDOXPLVDQDOWHUQDWLYHIRU)UHXQG¶VDGMXYDQW and can be used interchangeably in 
the study of the T-dependent response to NP. Before deciding on an adjuvant, it is recommended 
WRLQTXLUHZLWKWKHLQVWLWXWLRQ¶V,$&8&ZKLFKDGMXYDQWLVDFFHSWDEOH. 
(3) The analysis for somatic hypermutation in V186.2 rearrangements following NP-
immunization is commonly performed around days 12 to 14 after immunization, which is 
considered to be at the height of the GC reaction. 
(4) Different antibody combinations can be used to identify GC B cells, including the commonly 
used anti-CD95/anti-CD38 combination to identify CD95hiCD38lo GC B cells (13), and anti-
CD19 is a suitable alternative for anti-B220. GL7, which is highly expressed on GC B cells, can 
be used as an alternative for CD95, e.g. in the combination anti-GL7/anti-CD38.   
(5) When using an antibody-conjugate with PerCP, it need be ascertained that this fluorescence 
is compatible with the lasers and filters of the FACS sorter. As fluorescent colors, we suggest to 
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use FITC, PE and APC. If the cells are GFP-positive, consult with the operator of the flow 
cytometer which fluorescence can be used as an alternative to FITC.  
(6) The most suitable control for unmutated V186.2 rearrangements from antigen-inexperienced  
naïve B cells are B220+IgM+IgD+ splenic B cells (CD19 can be used as an alternative for B220). 
A suitable fluorochrome combination is B220-FITC, IgM-APC and IgD-PE. cDNA libraries 
generated with the CP cDNA primer as described in section 3.5.7 are amplified with the V186.2-
leader and CP-PCR primer in the 1st round and the V186.2-nested and CP-PCR primer in the 
second round (for PCR primers, see Table 1).  
(7) In principle, it is not necessary to flow-sort GC B cells or plasma cells for somatic 
hypermutation and affinity maturation analysis of rearranged V186.2 genes upon NP-
immunization. cDNA generated from whole splenic mononuclear cells or B cells isolated by 
magnetic cell separation can be used for the amplification of IgG1-expressing V186.2 gene 
segments (18). There is one caveat, however. Since plasma cells have much larger amounts of 
antibody-encoding Ig transcripts than memory B cells or GC B cells, the cDNA-based V186.2 
gene analysis is heavily skewed towards transcripts derived from plasma cells. To avoid this 
problem, V186.2 CJ1-membrane transcripts can be selectively amplified using the following 
strategy (18): RNA is reverse-transcribed with an oligonucleotide hybridizing in the CJ1-
membrane-encoding exon (mCJ1-cDNA oligo: ¶-TGACAGCAGCGCTGTAGCAC-¶ DQG
amplified for 30 cycles with the amplification conditions described in section 3.5.2.1 using the 
V186.2-leader primer (Table 1) and a reverse primer hybridizing in the CJ1-membrane-encoding 
exon (mCJ1-PCR oligo: ¶-CAGCACAGGTCTCGTCCAGTTG-¶ Generally, no nested PCR 
strategy is required, but can be implemented using the mCJ1-PCR and the V186.2-nested primer 
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described in section 3.5.2.2. All other cloning steps can be performed as described in sections 
3.5.2-3.5.4.   
(8) Somatic hypermutation analyses for V186.2 rearrangements are usually performed for IgG1 
antibodies. Since somatic hypermutation occurs in both switched and non-switched GC B cells, 
V186.2 P-transcripts may be analyzed as well. cDNA libraries generated with the CP-cDNA 
primer as described in section 3.5.7 are amplified with the V186.2-leader and CP-PCR primer in 
the 1st round and the V186.2-nested and CP-PCR primer in the second round (for PCR primers, 
see Table 1).            
(9) A strategy has been published that allows the amplification of V186.2 rearrangements from 
genomic DNA isolated from B-cell subsets (14). In our own experience, this strategy leads to the 
amplification of a large percentage of non-V186.2 gene segments (~40%), and unless there is a 
particular requirement to amplify V186.2 rearrangements from genomic DNA, in our opinion the 
cDNA-based approach is more cost effective.  
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Tables 
Table 1: Primers for cDNA synthesis and PCR amplification.  
_______________________________________________________ 
  CJ1-cDNA  ¶-CATGGAGTTAGTTTGGGCAG-¶ 
  CP-cDNA  ¶-CCACCAGATTCTTATCAGAC-¶ 
  V186.2-leader ¶-AGCTGTATCATGCTCTTCTTGGCA-¶ 
  V186.2-nested ¶-CATGCTCTTCTTGGCAGCAACAG-¶ 
  CJ1-PCR  ¶-ATCCAGGGGCCAGTGGATAGAC-¶ 
  CP-PCR  ¶-CGCAGGAGACGAGGGGGAAGAC-¶ 
________________________________________________________ 
Figure legends 
Fig. 1. Experimental flow: Analysis of NP-specific serum Ig by ELISA and ELISPOT for 
anti-NP-specific IgG1 plasma cells. The major experimental steps are indicated and 
representative examples for ELISA and ELISPOT results are shown. SMC, splenic mononuclear 
cells; BMC, bone marrow cells.     
Fig. 2. Experimental flow: Analysis of V186.2-CJ1 rearrangements for somatic 
hypermutation and affinity maturation. The major experimental steps are indicated. 
Representative examples for the isolation of B220+PNAhiCD95hi GC B cells and B220loCD138hi 
plasma cells are shown. A representative example for the analysis of somatic hypermutation and 
the analysis for codon 33 mutation using VBASE2 (17) are indicated; in VBASE2, codon 33 of 
V186.2 is found at position 34. FSC, forward scatter; SSC, side scatter.    
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